Telo Genomics Corp (TELO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 14 | 40 | 33 | 57 | 62 |
| Accounts receivable | 5 | 33 | -26 | 59 | -47 |
| Other Working Capital | 41 | 158 | -2 | 107 | -51 |
| Other Operating Activity | -2,389 | -2,689 | -2,635 | -2,018 | -1,068 |
| Operating Cash Flow | $-2,329 | $-2,459 | $-2,630 | $-1,795 | $-1,105 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -5 | -69 | -25 | -9 |
| Investing Cash Flow | $-3 | $-5 | $-69 | $-25 | $-9 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | -23 | -8 | 0 | -15 |
| Common Stock Issued | 2,546 | 650 | 2,834 | 195 | 2,093 |
| Other Financing Activity | -221 | -40 | -147 | 682 | 1,752 |
| Financing Cash Flow | $2,325 | $587 | $2,679 | $877 | $3,829 |
| Beginning Cash Position | 796 | 2,673 | 2,693 | 3,637 | 921 |
| End Cash Position | 789 | 796 | 2,673 | 2,693 | 3,637 |
| Net Cash Flow | $-7 | $-1,877 | $-20 | $-944 | $2,716 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,329 | -2,459 | -2,630 | -1,795 | -1,105 |
| Capital Expenditure | -3 | -5 | -69 | -25 | -9 |
| Free Cash Flow | -2,332 | -2,464 | -2,699 | -1,820 | -1,114 |